FOLH1 and prostate carcinoma: The role of PSMA-PET in evaluating patients with prostate cancer is well known.17PSMA is also overexpressed in the neo-vasculature of other tumors, including RC,18suggesting that there may be a role for the use of PET/CT with PSMA in this pathology.